Scientific Findings Can't Yield False Ad Claims, 2nd Circ. Says
By Melissa Lipman (June 26, 2013, 6:32 PM EDT) -- The Second Circuit ruled Wednesday that scientific conclusions voiced during debate of unsettled questions can't generate false advertising or deceptive business practices claims, rejecting ONY Inc.'s claims against a rival biopharmaceutical company.
A three-judge panel upheld the dismissal of ONY's case accusing rival Chiesi Farmaceutici SpA, several scientists and a scientific journal of violating the Lanham Act's ban on false advertising and New York state law by publishing and redistributing a study arguing that Chiesi's lung surfactant product was more effective than ONY's.
The judges concluded that the scientific hypotheses and findings presented in the paper were more akin to opinion,...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!